NasdaqCM - Nasdaq Real Time Price USD
Dianthus Therapeutics, Inc. (DNTH)
18.31
-0.98
(-5.08%)
At close: June 13 at 4:00:01 PM EDT
18.31
0.00
(0.00%)
After hours: June 13 at 4:36:06 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jan 22, 2024 | -- |
| MENG LEI Director | Stock Award(Grant) | Jan 22, 2024 | -- |
| MOULDER LEON OLIVER JR. Director | Stock Award(Grant) | Jan 22, 2024 | -- |
| RANDHAWA SIMRAT Officer | Purchase | Sep 22, 2023 | 4,000 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
17.29
-2.37%
ACTU Actuate Therapeutics, Inc. Common stock
8.65
+0.46%
VRDN Viridian Therapeutics, Inc.
15.88
+1.34%
SRZN Surrozen, Inc.
9.48
+0.82%
AVBP ArriVent BioPharma, Inc.
23.27
-1.52%
CTX.WA Captor Therapeutics Spolka Akcyjna
33.60
-2.61%
TRML Tourmaline Bio, Inc.
19.68
-1.11%
4588.T Oncolys BioPharma Inc.
613.00
-0.97%
CNTA Centessa Pharmaceuticals plc
12.38
+2.82%
475830.KQ Orum Therapeutics, Inc.
17,820.00
-0.83%